Status:
RECRUITING
Post COVID-19 Biorepository
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
Establish a biorepository, clinical data registry, and radiographic image database from individuals who were COVID positive at one time and are being seen for outpatient follow-up or a separate study ...
Detailed Description
Living patients or their healthcare surrogates will provide informed consent prior to participation in the biorepository. Surrogate decision makers who cannot consent in person will be consented in ac...
Eligibility Criteria
Inclusion
- The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP).
- The participant has a previous diagnosis of COVID-19 confirmed by COVID-19 PCR or antibody testing and is being seen for outpatient follow-up.
- Patient is ≥ 18 years of age or older.
Exclusion
- Participant declines to participate.
- Participant or healthcare surrogate is unable to provide informed consent.
Key Trial Info
Start Date :
February 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04885504
Start Date
February 8 2021
End Date
July 15 2026
Last Update
August 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160